BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 37308716)

  • 1. Insights into recent findings and clinical application of YAP and TAZ in cancer.
    Franklin JM; Wu Z; Guan KL
    Nat Rev Cancer; 2023 Aug; 23(8):512-525. PubMed ID: 37308716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the ambivalent role of YAP/TAZ in human cancers.
    Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P
    J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAZ/YAP fusion proteins: mechanistic insights and therapeutic opportunities.
    Garcia K; Gingras AC; Harvey KF; Tanas MR
    Trends Cancer; 2022 Dec; 8(12):1033-1045. PubMed ID: 36096997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
    Shreberk-Shaked M; Oren M
    Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S
    EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of YAP/TAZ in ferroptosis.
    Magesh S; Cai D
    Trends Cell Biol; 2022 Sep; 32(9):729-732. PubMed ID: 35701310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation.
    Damkham N; Lorthongpanich C; Klaihmon P; Lueangamornnara U; Kheolamai P; Trakarnsanga K; Issaragrisil S
    Stem Cell Res Ther; 2022 Sep; 13(1):467. PubMed ID: 36076260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Regulation of Yap/Taz from Cellular Systems and Mouse Models.
    Du W; Du W; Wan M; Zhou X; Xu X; Zheng L
    Curr Stem Cell Res Ther; 2018; 13(1):16-25. PubMed ID: 28042766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP/TAZ at the Roots of Cancer.
    Zanconato F; Cordenonsi M; Piccolo S
    Cancer Cell; 2016 Jun; 29(6):783-803. PubMed ID: 27300434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncogenic roles and clinical implications of YAP/TAZ in breast cancer.
    Luo J; Zou H; Guo Y; Tong T; Chen Y; Xiao Y; Pan Y; Li P
    Br J Cancer; 2023 May; 128(9):1611-1624. PubMed ID: 36759723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of myocardial glucose metabolism by YAP/TAZ signaling.
    Kashihara T; Sadoshima J
    J Cardiol; 2024 May; 83(5):323-329. PubMed ID: 38266816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.
    Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL
    J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies.
    Kim MH; Kim J
    Cell Mol Life Sci; 2017 Apr; 74(8):1457-1474. PubMed ID: 27826640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers.
    Howard A; Bojko J; Flynn B; Bowen S; Jungwirth U; Walko G
    Exp Dermatol; 2022 Oct; 31(10):1477-1499. PubMed ID: 35913427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo pathway-independent restriction of TAZ and YAP by angiomotin.
    Chan SW; Lim CJ; Chong YF; Pobbati AV; Huang C; Hong W
    J Biol Chem; 2011 Mar; 286(9):7018-26. PubMed ID: 21224387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers.
    Wang Y; Chen H; Yu J; Kang W; To KF
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188787. PubMed ID: 36041574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC.
    Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS
    Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP and TAZ differentially regulate postnatal cortical progenitor proliferation and astrocyte differentiation.
    Chen J; Tsai YH; Linden AK; Kessler JA; Peng CY
    J Cell Sci; 2024 May; 137(10):. PubMed ID: 38639242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.